Van den Bergh's test
Van den Bergh's test is a clinical laboratory test used in the diagnosis and monitoring of liver disease and bilirubin metabolism disorders. This test differentiates between direct (conjugated) and indirect (unconjugated) bilirubin in a patient's blood serum, providing valuable information about liver function, bile duct patency, and the presence of certain diseases.
Background[edit | edit source]
Bilirubin is a yellow compound that occurs in the blood as a breakdown product of hemoglobin from red blood cells. Normally, bilirubin is processed in the liver, where it is conjugated (made water-soluble) and then excreted in bile. The Van den Bergh reaction, developed by Adrianus Van den Bergh and his colleagues in the early 20th century, is a chemical test that distinguishes between conjugated bilirubin, which reacts directly with the reagent (direct positive), and unconjugated bilirubin, which requires the presence of alcohol to facilitate the reaction (indirect positive).
Procedure[edit | edit source]
The Van den Bergh test involves adding a diazo reagent to the serum sample. In the presence of direct bilirubin, a red-colored compound forms immediately, indicating a direct (or conjugated) positive result. If no color change occurs, alcohol is then added to the mixture, and the development of a red color after this addition indicates the presence of indirect (or unconjugated) bilirubin.
Clinical Significance[edit | edit source]
The results of the Van den Bergh test are significant in diagnosing and managing conditions such as jaundice, hepatitis, cirrhosis, and Gilbert's syndrome. Elevated levels of direct bilirubin may indicate liver dysfunction or obstruction of the bile ducts, while high levels of indirect bilirubin may suggest hemolytic anemia or other conditions leading to increased breakdown of red blood cells.
Limitations[edit | edit source]
While the Van den Bergh test provides essential information about bilirubin metabolism and liver function, it has been largely replaced by more modern, automated methods that offer greater sensitivity and specificity. However, understanding the principles behind this test remains important for medical professionals studying liver diseases and bilirubin metabolism.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD